医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Now, Get A Free Knock-out Mouse: The Improved Sperm-freezing Technology Enables Macrogen to Open the Overseas Genetically-Engineered Mice Market

2020年03月02日 PM11:00
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

Macrogen (KOSDAQ: 038290), the Korean precision medicine biotech company, is hosting a ‘Now, Get A Free Knock-out Mouse!’ event on a first-come, first-served basis.

The ‘Now, Get A Free Knock-out Mouse’ is Macrogen’s first ambitious launching event of GEM (Genetically-Engineered Mice)-related product offering to overseas customers. To celebrate this, the event will be provided to researchers in the United States, Europe, and Asia (excluding some Asian countries). When customers apply for Macrogen’s CRISPR KO Mouse service, they can receive a KO (Knock-Out) mouse for free, which is over $10,000. The event will be held from March 1 to June 30.

KO is a technique that removes or transforms certain genes to produce KO mice with new characteristics. Macrogen utilizes the CRISPR gene-editing technology to provide KO Mouse in a faster and more efficient way. Currently, KO mouse is widely used throughout the world in the non-clinical phase of new drug development, safety, and validation.

This event was made possible by Macrogen’s advanced technology developed for the sperm cryopreservation. The improved technology enabled Macrogen to ship the frozen sperms of the GEM rather than shipping live animals, which is very hard and costly. Compared with the existing sperm cryopreservation technology, the enhanced technology has increased the research efficiency by 30% by improving the birth rate from the fertilized eggs by frozen sperm. Macrogen manufactures the disease model mouse requested by the customer, and then collects the sperm of the mouse and delivers it to the customer in a cryopreserved state. Customers can use cryopreserved sperm and the protocols provided to reproduce mice with much higher efficiency.

Macrogen is Korea’s only GEM manufacturing company with facilities ranging from GEM custom-made services to SPF (Specific Pathogen Free). The company is the top company producing the largest number of the model animals in Korea. Macrogen has been providing disease model mice since 1997 and has 23 years of expertise. The company also acquired the license of CRISPR-Cas9 gene-editing technology from Broad Institute in the United States in 2018 and has been using the technology for producing model mice with enhanced productivity.

For more information, please visit dna.macrogen.com and customers who want to participate in the event can get detailed information by sending an e-mail to mouse@macrogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200302005387/en/

CONTACT

Macrogen Inc.

Young-kyu Lee, +82-2-3663-2004

mouse@macrogen.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 武田通过与Moderna和日本政府合作,在日本扩大COVID-19疫苗供货
  • ABEC将向百因诺生物交付业内首台6000L一次性生物反应器
  • The McQuade Center for Strategic Research and Development Enters Collaboration Agreement with Rugen Holdings (Cayman) Limited to Develop Novel Treatment for Patients with Diverse Psychiatric Disorders
  • Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
  • 国連世界都市デーを機に、G20のアーバン20(U20)エンゲージメント・グループがCOVID-19を受けて「世界都市強靭性基金」の創設を発表